Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.

Da-Wei ShiZiye ZhouYing DaiXiaofeng PanQinqin Cao

Published in: Clinical drug investigation (2020)

We found PPI therapy increased the risk of HE in cirrhotic patients, and higher risk was found in post-operative TIPS. Additional studies are warranted to inform clinical decision making.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
decision making
stem cells
patient reported outcomes
mesenchymal stem cells
bone marrow
smoking cessation